The introduction of Retatrutide in the UK is creating significant anticipation within the obesity community. This novel dual compound – targeting both GLP-1 and GIP – offers a significantly new solution to addressing excess weight . Until recently, options have been constrained for many, and Retatrutide represents a promising possibility for in